Accessibility Tools

  • Content scaling 100%
  • Font size 100%
  • Line height 100%
  • Letter spacing 100%

Prima Facie

The return of the Griffin production
Melbourne Theatre Company
by
ABR Arts 13 February 2023

Prima Facie

The return of the Griffin production
Melbourne Theatre Company
by
ABR Arts 13 February 2023
Sheridan Harbridge as Tessa Ensler (photograph by Brett Boardman).
Sheridan Harbridge as Tessa Ensler (photograph by Brett Boardman).

Since first being produced at Sydney’s Griffin Theatre in 2019, Suzie Miller’s play Prima Facie – a legal drama about consent and sexual violence – has become something of a phenomenon. Awarded Griffin Theatre’s playwriting prize in 2018, the subsequent production was enthusiastically received by audiences and critics alike. A 2022 West End production – propelled by the star power of Killing Eve’s Jodie Comer – garnered international acclaim, the National Theatre’s live screening of the production becoming one of 2022’s highest grossing British films. In 2023, the West End production moves to Broadway, while in Melbourne, the Melbourne Theatre Company’s six-week remounting of the original Griffin production – the production reviewed here – sold out before its first performance. If that wasn’t enough, a screen adaptation of the play is in the works, so too a novel, both helmed by Miller.

Miller’s writing has long been concerned with themes of social justice and the equitable negotiation of relationships, whether those relationships be marital, familial, or sexual. In Prima Facie, these themes are actualised in the plight of Tessa Ensler (Sheridan Harbridge), a criminal barrister who finds herself on the wrong side of the judicial process. Here, Miller borrows a trope frequently employed in medical narratives: the surgeon who finds themselves under the knife, the oncologist enduring chemotherapy. Tessa’s accusation that she was raped by one of her colleagues exposes her to the deficiencies of a legal system in which she has, as a lawyer herself, invested so much faith.

From the New Issue

Leave a comment

If you are an ABR subscriber, you will need to sign in to post a comment.

If you have forgotten your sign in details, or if you receive an error message when trying to submit your comment, please email your comment (and the name of the article to which it relates) to ABR Comments. We will review your comment and, subject to approval, we will post it under your name.

Please note that all comments must be approved by ABR and comply with our Terms & Conditions.